Brief: Arch Biopartners closes convertible note financing
24/10/2017 13:00
Oct 24 (Reuters) - Arch Biopartners ARCH.V
* Arch Biopartners closes convertible note financing
* Closed an unsecured convertible note financing for gross
proceeds of C$500,000
Source text for Eikon: ID:nCCNvMSMNa
Further company coverage: ARCH.V
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide